Motor Neuron

Disabled Filmmaker Patrick O’Brien Turns 34, Film Nears Completion

Silver Spring, MD (PRWEB) October 7, 2008

On the occasion of his 34th birthday, Patrick O’Brien is not only happy to be alive, he is beaming over the near completion of his first major film.

Only a few years ago, Patrick, then known as the wildly outrageous “Transfatty” to the New York City creative underground, could not have imagined a more perfect or compelling story line. Always

Continue Reading Disabled Filmmaker Patrick O’Brien Turns 34, Film Nears Completion

Tags: Completion, Disabled, Film, Filmmaker, Nears, O'Brien, Patrick, Turns

Boston Neurobiologist Receives Grant to Battle Leading Genetic Killer of Infants and Toddlers

New York, NY (PRWEB) April 1, 2005 -

The Spinal Muscular Atrophy Foundation announced that the recipient of this year’s Young Investigator Award in Spinal Muscular Atrophy (SMA) is Mustafa Sahin, MD, PhD, from Children’s Hospital Boston. Dr. Sahin, a neurobiologist specializing in child neurology, will conduct new research on SMA – the leading genetic killer of infants and toddlers and a disease which

Continue Reading Boston Neurobiologist Receives Grant to Battle Leading Genetic Killer of Infants and Toddlers

Tags: Battle, Boston, Genetic, Grant, Infants, Killer, Leading, Neurobiologist, Receives, Toddlers

MD Biosciences Preclinical Efficacy Models of Parkinson’s Disease: 6OHDA and Acute MPTP

Whitepaper: What in vivo models of PD have revealed about pathogenesis and treatment.

St Paul, MN (PRWEB) August 11, 2010

MD Biosciences, a Preclinical Contract Research Organization (CRO), offers in vivo models for the study of Parkinson’s Disease (PD). The 6-OHDA and acute MPTP models for PD have been well characterized with the underlying mechanisms of toxicity well understood. Both models are

Continue Reading MD Biosciences Preclinical Efficacy Models of Parkinson’s Disease: 6OHDA and Acute MPTP

Tags: 6OHDA, Acute, Biosciences, Disease, Efficacy, Models, MPTP, Parkinson's, Preclinical